Pain Management

Latest Content


A study in Canada of nearly 4000 patients with chronic pain found that one-third reported coexisting chronic pain conditions, but no specific patterns of co-occurrence of pain comorbidity were identified. The study was conducted to add more to the body of knowledge about what is known about chronic pain, which is experienced by up to 20% of the population.

Patients having total knee arthroplasty treated with liposomal bupivacaine were discharged to their homes sooner and had a significantly shorter hospital stay compared with patients who did not receive the drug during surgery, according to a recently published study looking at the value and cost effectiveness of the drug.

Topical analgesics were safe and effective at reducing chronic pain, according to a study that also looked at whether or not a subgroup of patients were able to stop using opioids a few months after treatment. About 50% of patients were able to discontinue use of opioids after 3 or 6 months of treatment with pain-relieving analgesics applied directly to the skin, a study reported.

Examining insurance claims from millions of doctors' visits with daily rainfall totals from thousands of National Oceanic and Atmospheric Administration weather stations showed that there is no relationship between rainy weather and joint pain or an achy back, according to new research from Harvard Medical School.

Most studies on the potential of marijuana, classic hallucinogens, 3,4-methylenedioxymethamphetamine, and ketamine have been small with methodological flaws, but the promising results from existing studies suggest that larger studies are warranted, said William M. Suavé, MD, medical director, Greenbrook TMS NeuroHealth Centers, during a presentation on the therapeutic potential of illicit drugs.

A review of some of the presentations at the American College of Rheumatology (ACR) 2017 Annual Meeting, in San Diego, California, where the discussions ranged from clinical progress witnessed in 2017 for the treatment of inflammatory conditions to reimbursement models in the rheumatology space.